| Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling R Pidsley, E Zotenko, TJ Peters, MG Lawrence, GP Risbridger, P Molloy, ... Genome biology 17, 1-17, 2016 | 1327 | 2016 |
| Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci FR Schumacher, AA Al Olama, SI Berndt, S Benlloch, M Ahmed, ... Nature genetics 50 (7), 928-936, 2018 | 890 | 2018 |
| Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development GR Cunha, W Ricke, A Thomson, PC Marker, G Risbridger, SW Hayward, ... The Journal of steroid biochemistry and molecular biology 92 (4), 221-236, 2004 | 419 | 2004 |
| Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction DV Conti, BF Darst, LC Moss, EJ Saunders, X Sheng, A Chou, ... Nature genetics 53 (1), 65-75, 2021 | 393 | 2021 |
| Breast and prostate cancer: more similar than different GP Risbridger, ID Davis, SN Birrell, WD Tilley Nature Reviews Cancer 10 (3), 205-212, 2010 | 329 | 2010 |
| Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer MJ Watt, AK Clark, LA Selth, VR Haynes, N Lister, R Rebello, LH Porter, ... Science translational medicine 11 (478), eaau5758, 2019 | 303 | 2019 |
| Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling WA Ricke, SJ McPherson, JJ Bianco, GR Cunha, Y Wang, GP Risbridger The FASEB journal 22 (5), 1512-1520, 2008 | 279 | 2008 |
| Activins and inhibins in endocrine and other tumors GP Risbridger, JF Schmitt, DM Robertson Endocrine reviews 22 (6), 836-858, 2001 | 277 | 2001 |
| The dual, opposing roles of estrogen in the prostate SJ Ellem, GP Risbridger Annals of the New York Academy of Sciences 1155 (1), 174-186, 2009 | 257 | 2009 |
| Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories RA Taylor, M Fraser, J Livingstone, SMG Espiritu, H Thorne, V Huang, ... Nature communications 8 (1), 13671, 2017 | 250 | 2017 |
| Estrogen receptor–β activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFα mediated SJ McPherson, S Hussain, P Balanathan, SL Hedwards, B Niranjan, ... Proceedings of the National Academy of Sciences 107 (7), 3123-3128, 2010 | 240 | 2010 |
| Evidence that epithelial and mesenchymal estrogen receptor-α mediates effects of estrogen on prostatic epithelium G Risbridger, H Wang, P Young, T Kurita, YZ Wong, D Lubahn, ... Developmental Biology 229 (2), 432-442, 2001 | 235 | 2001 |
| Local aromatase expression in human prostate is altered in malignancy SJ Ellem, JF Schmitt, JS Pedersen, M Frydenberg, GP Risbridger The Journal of Clinical Endocrinology & Metabolism 89 (5), 2434-2441, 2004 | 218 | 2004 |
| Elevated androgens and prolactin in aromatase-deficient mice cause enlargement, but not malignancy, of the prostate gland SJ McPherson, H Wang, ME Jones, J Pedersen, TP Iismaa, N Wreford, ... Endocrinology 142 (6), 2458-2467, 2001 | 218 | 2001 |
| Combined TP53 and RB1 loss promotes prostate cancer resistance to a spectrum of therapeutics and confers vulnerability to replication stress MD Nyquist, A Corella, I Coleman, N De Sarkar, A Kaipainen, G Ha, ... Cell reports 31 (8), 2020 | 212 | 2020 |
| Aromatase and regulating the estrogen: androgen ratio in the prostate gland SJ Ellem, GP Risbridger The Journal of steroid biochemistry and molecular biology 118 (4-5), 246-251, 2010 | 203 | 2010 |
| Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development T Bianco-Miotto, K Chiam, G Buchanan, S Jindal, TK Day, M Thomas, ... Cancer epidemiology, biomarkers & prévention 19 (10), 2611-2622, 2010 | 196 | 2010 |
| Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones RA Jarred, M Keikha, C Dowling, SJ McPherson, AM Clare, AJ Husband, ... Cancer Epidemiology Biomarkers & Prevention 11 (12), 1689-1696, 2002 | 190 | 2002 |
| Oestrogens and prostate cancer. GP Risbridger, JJ Bianco, SJ Ellem, SJ McPherson Endocrine-Related Cancer 10 (2), 187-191, 2003 | 178 | 2003 |
| Immuno-and bioactive inhibin and inhibin α-subunit expression in rat Leydig cell cultures GP Risbridger, J Clements, DM Robertson, AE Drummond, J Muir, ... Molecular and Cellular Endocrinology 66 (1), 119-122, 1989 | 169 | 1989 |
Renea TaylorMonash UniversityVerified email at monash.edu